Clinical Trials Browser

Interventional × Small Bowel Adenocarcinoma × 30 days × Clear all

NCT06835387 2026-06-04

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

Phase 2 Recruiting

Gastrointestinal

Small Bowel Adenocarcinoma